- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beta Drugs Ltd (BTAD)
Beta Drugs Ltd stock price live, this page displays NSE BTAD stock exchange data. View the BTAD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beta Drugs Ltd real time stock price chart below.
What Is the Beta Drugs Ltd Stock Price Today?
The Beta Drugs Ltd stock price today is 2,139.80.
What Is the Stock Symbol for Beta Drugs Ltd?
The stock symbol for Beta Drugs Ltd is "BTAD."
What Stock Exchange Does Beta Drugs Ltd Trade On?
Beta Drugs Ltd is listed and trades on the NSE stock exchange.
Is Beta Drugs Ltd a Good Stock to Buy?
Determining whether Beta Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTAD quote. (ISIN: INE351Y01019)
What Is the Beta Drugs Ltd Stock Price Today?
The Beta Drugs Ltd stock price today is 2,139.80.
What Is the Stock Symbol for Beta Drugs Ltd?
The stock symbol for Beta Drugs Ltd is "BTAD."
What Stock Exchange Does Beta Drugs Ltd Trade On?
Beta Drugs Ltd is listed and trades on the NSE stock exchange.
Is Beta Drugs Ltd a Good Stock to Buy?
Determining whether Beta Drugs Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BTAD quote. (ISIN: INE351Y01019)
NSE
Currency in INR
2,139.80
+15.90(+0.75%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,115.00
2,173.90
52 wk Range
990.10
2,807.90
BTAD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,115.002,173.90
52 wk Range
990.102,807.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BTAD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Jul 20, 2026
EPS / Forecast
14.78 / --
Revenue / Forecast
1.26B / --
Compare BTAD to Peers and Sector
Metrics to compare | BTAD | Peers Peers - average of corresponding metrics from companies closely matching BTAD: TRENT, ROTO, BSE, LAXMIDENTL, VMART | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBTADPeersSector |
|---|---|---|---|---|
P/E Ratio | 47.0x | 37.9x | −0.4x | |
PEG Ratio | 7.01 | 0.45 | 0.00 | |
Price/Book | 8.8x | 5.0x | 2.6x | |
Price / LTM Sales | 5.2x | 4.0x | 3.0x | |
Upside (Analyst Target) | - | 9.9% | 49.0% | |
Fair Value Upside | Unlock | 3.1% | 6.5% | Unlock |
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Beta Drugs (BTAD) Stock Price Today?
The Beta Drugs stock price today is 2,139.80 INR.
What Stock Exchange Does Beta Drugs Trade On?
Beta Drugs is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Beta Drugs?
The stock symbol for Beta Drugs is "BTAD."
What Is the Beta Drugs Market Cap?
As of today, Beta Drugs market cap is 21.44B INR.
What Is Beta Drugs's Earnings Per Share (TTM)?
The Beta Drugs EPS (TTM) is 44.31.
When Is the Next Beta Drugs Earnings Date?
Beta Drugs will release its next earnings report on Oct 28, 2026.
From a Technical Analysis Perspective, Is BTAD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Beta Drugs Stock Split?
Beta Drugs has split 1 times.
How Many Employees Does Beta Drugs Have?
Beta Drugs has 399 employees.
What is the current trading status of Beta Drugs (BTAD)?
As of Sep 08, 2026, Beta Drugs (BTAD) is trading at a price of 2,139.80 INR, with a previous close of 2,123.90 INR. The stock has fluctuated within a day range of 2,115.00 INR to 2,173.90 INR, while its 52-week range spans from 990.10 INR to 2,807.90 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.